Search research articles
Contact Us
Filters
Showing results (171-180 of 194) with videos related to
Page
of 20
Sort By:
Clinical Pharmacokinetics
|
December 20, 2019
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug Interactions
Xia Li, Sebastian Frechen, Daniel Moj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial
Thomas Schmitt, Hartmut Goldschmidt, Kai Neben, et al.
Therapeutic Advances in Psychopharmacology
|
December 5, 2017
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
Andreas D Meid, Irene Bighelli, Sarah Mächler, et al.
NPJ Vaccines
|
February 7, 2020
Immunization with full-length <i>Plasmodium falciparum</i> merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial
Antje Blank, Kristin Fürle, Anja Jäschke, et al.
European Journal of Clinical Pharmacology
|
December 25, 2004
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
Jens Rengelshausen, Jürgen Burhenne, Margit Fröhlich, et al.
Clinical Pharmacology in Drug Development
|
July 16, 2021
Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug-Drug Interaction Trial in Healthy Adults
Felicitas Stoll, Antje Blank, Gerd Mikus, et al.
Infection
|
April 25, 2025
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study
Franz Weber, Christina Scharf, Linda B S Aulin, et al.
Tropical Medicine & International Health : TM & IH
|
April 9, 2010
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso
Mamadou Bountogo, Augustin Zoungrana, Boubacar Coulibaly, et al.
Cardiovascular Drugs and Therapy
|
December 19, 2023
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin
Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 12, 2023
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 194) with videos related to
Sort By:
Page
of 20
Clinical Pharmacokinetics
|
December 20, 2019
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug Interactions
Xia Li, Sebastian Frechen, Daniel Moj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial
Thomas Schmitt, Hartmut Goldschmidt, Kai Neben, et al.
Therapeutic Advances in Psychopharmacology
|
December 5, 2017
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
Andreas D Meid, Irene Bighelli, Sarah Mächler, et al.
NPJ Vaccines
|
February 7, 2020
Immunization with full-length <i>Plasmodium falciparum</i> merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial
Antje Blank, Kristin Fürle, Anja Jäschke, et al.
European Journal of Clinical Pharmacology
|
December 25, 2004
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
Jens Rengelshausen, Jürgen Burhenne, Margit Fröhlich, et al.
Clinical Pharmacology in Drug Development
|
July 16, 2021
Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug-Drug Interaction Trial in Healthy Adults
Felicitas Stoll, Antje Blank, Gerd Mikus, et al.
Infection
|
April 25, 2025
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study
Franz Weber, Christina Scharf, Linda B S Aulin, et al.
Tropical Medicine & International Health : TM & IH
|
April 9, 2010
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso
Mamadou Bountogo, Augustin Zoungrana, Boubacar Coulibaly, et al.
Cardiovascular Drugs and Therapy
|
December 19, 2023
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin
Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 12, 2023
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, et al.
Page
of 20